Antiretroviral therapy has decreased the risk of lymphoma in the HIV-positive patient population, yet the incidence is still approximately 70-times greater than the incidence in the noninfected ...
Survival of patients with HIV-DLCL has improved in the HAART era, along with CD4 count, whereas survival of similarly treated patients with HIV-BL remained poor. The current practice of using the same ...
AIDS Rev. 2008;10(2):125-126. At the beginning of the HIV pandemic, most complications in AIDS subjects were due to infectious diseases. After the introduction of HAART in 1996, survival dramatically ...
The intersection of HIV infection and lymphoma has long presented clinical challenges, with HIV-associated lymphomas comprising both AIDS-defining and non-AIDS-defining cancers. Recent advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results